TAVI Head-To-Head: Design, Data and Directions for Clinical Practice
Published: 07 May 2024
-
Views:
600 -
Likes:
7
-
Views:
600 -
Likes:
7
-
16m 19sPart 4 Improving Access
-
3m 43sPart 1 Introduction Martin Swaans, Sabine Bleiziffer, Vijay Kunadian, Marta Sitges
-
16m 1sPart 2 TAVI: Current Status and Valve Durability Marta Sitges
Overview
In this on-demand version of the live broadcast, chaired by Dr Martin Swaans (St Antonius Hospital, NL), faculty explore the evolving data for transcatheter aortic valve implantation (TAVI) and why we need to improve triaging practices towards the most appropriate interventions.
Leading experts, Prof Sabine Bleiziffer (Heart and Diabetes Center NRW, DE), Prof Vijay Kunadian (Newcastle University, UK) and Dr Marta Sitges (Hospital Clínic de Barcelona, ES), discuss valve design and durability, clinical data from the SMART trial presented at ACC 2024 and how we can provide greater access for women in TAVI.
Learning Objectives
- Recall TAVI SMART trial data and the implications on clinical practice
- Describe novel valve designs and the impact on long-term performance
- Develop an expert-led approach to improving equitable access to TAVI
Target Audience
- General Cardiologists
- Echocardiographers
- Physiologists
- Physicians referring patients for TAVI
- Interventional Cardiologists
- Cardiac Surgeons
More from this programme
Part 1
Introduction
1 session | |
Introduction | Watch now |
Part 2
TAVI: Current Status and Valve Durability
Part 3
Data from the ACC 2024
1 session | |
Data from the ACC 2024 | Watch now |
Part 4
Improving Access
1 session | |
Improving Access | Watch now |
Part 5
Panel Discussion and Audience Q&A
1 session | |
Panel Discussion and Audience Q&A | Watch now |
Faculty Biographies
Sabine Bleiziffer
Senior Consultant Cardiac Surgeon
Prof Sabine Bleiziffer is a Senior Consultant Cardiac Surgeon at Heart and Diabetes Center NRW, Bad Oeynhausen, DE.
She graduated from the University of Leipzig and the Ludwig Maximilian University in Munich, Germany.
Prof Bleiziffer focuses on structural valve diseases.
Comments